Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Methotrexate Exposure and Risk of Strongyloidiasis.

Richards C, Penner J, Colmegna I, Loewen H, Melaku Z, Melkie A, Meltzer M, Scuccimarri R, Mengistu Y, Hitchon CA.

Trop Med Int Health. 2019 Jul 14. doi: 10.1111/tmi.13288. [Epub ahead of print]

PMID:
31302948
2.

Human host defence peptide LL37 and anti-cyclic citrullinated peptide antibody in early inflammatory arthritis.

Hitchon CA, Meng X, El Gabalawy HS, Larcombe L.

RMD Open. 2019 Apr 29;5(1):e000874. doi: 10.1136/rmdopen-2018-000874. eCollection 2019.

3.

The validity and reliability of screening measures for depression and anxiety disorders in rheumatoid arthritis.

Hitchon CA, Zhang L, Peschken CA, Lix LM, Graff LA, Fisk JD, Patten SB, Bolton J, Sareen J, El-Gabalawy R, Marriott J, Bernstein CN, Marrie R.

Arthritis Care Res (Hoboken). 2019 Jun 14. doi: 10.1002/acr.24011. [Epub ahead of print]

PMID:
31199570
4.

Treatment strategies in early rheumatoid arthritis methotrexate management: Results from a prospective cohort.

Moura CS, Schieir O, Valois MF, Thorne C, Bartlett SJ, Pope JE, Hitchon CA, Boire G, Haraoui B, Hazlewood GS, Keystone EC, Tin D, Bykerk VP, Bernatsky S; Canadian Early Arthritis Cohort (CATCH) Investigators.

Arthritis Care Res (Hoboken). 2019 May 21. doi: 10.1002/acr.23927. [Epub ahead of print]

PMID:
31112011
5.

Prevalence and Incidence of Rheumatoid Arthritis in Canadian First Nations and Non-First Nations People: A Population-Based Study.

Hitchon CA, Khan S, Elias B, Lix LM, Peschken CA.

J Clin Rheumatol. 2019 Jan 22. doi: 10.1097/RHU.0000000000001006. [Epub ahead of print]

PMID:
30676383
6.

Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders.

Whitehouse CE, Fisk JD, Bernstein CN, Berrigan LI, Bolton JM, Graff LA, Hitchon CA, Marriott JJ, Peschken CA, Sareen J, Walker JR, Stewart SH, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Neurology. 2019 Jan 11. pii: 10.1212/WNL.0000000000006854. doi: 10.1212/WNL.0000000000006854. [Epub ahead of print]

PMID:
30635487
7.

Persistent Disease Activity Remains a Burden for Patients with Systemic Lupus Erythematosus.

Peschken CA, Wang Y, Abrahamowicz M, Pope J, Silverman E, Sayani A, Iczkovitz S, Ross J, Zummer M, Tucker L, Pineau C, Levy D, Hudson M, Hitchon CA, Huber AM, Smith CD, Avina-Zubieta A, Arbillaga H, Chédeville G, Wynant W, Fortin PR; CaNIOS 1000 Faces Investigators.

J Rheumatol. 2019 Feb;46(2):166-175. doi: 10.3899/jrheum.171454. Epub 2018 Sep 15.

PMID:
30219771
8.

Increased Burden of Psychiatric Disorders in Inflammatory Bowel Disease.

Bernstein CN, Hitchon CA, Walld R, Bolton JM, Sareen J, Walker JR, Graff LA, Patten SB, Singer A, Lix LM, El-Gabalawy R, Katz A, Fisk JD, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Inflamm Bowel Dis. 2019 Jan 10;25(2):360-368. doi: 10.1093/ibd/izy235.

PMID:
29986021
9.

Psychiatric comorbidity increases mortality in immune-mediated inflammatory diseases.

Marrie RA, Walld R, Bolton JM, Sareen J, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Gen Hosp Psychiatry. 2018 Jul - Aug;53:65-72. doi: 10.1016/j.genhosppsych.2018.06.001. Epub 2018 Jun 7.

10.

The association of fatigue, pain, depression and anxiety with work and activity impairment in immune mediated inflammatory diseases.

Enns MW, Bernstein CN, Kroeker K, Graff L, Walker JR, Lix LM, Hitchon CA, El-Gabalawy R, Fisk JD, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

PLoS One. 2018 Jun 7;13(6):e0198975. doi: 10.1371/journal.pone.0198975. eCollection 2018.

11.

The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease.

Bernstein CN, Zhang L, Lix LM, Graff LA, Walker JR, Fisk JD, Patten SB, Hitchon CA, Bolton JM, Sareen J, El-Gabalawy R, Marriott J, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease.

Inflamm Bowel Dis. 2018 Apr 13. doi: 10.1093/ibd/izy068. [Epub ahead of print]

PMID:
29668911
12.

Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis.

Marrie RA, Hitchon CA, Walld R, Patten SB, Bolton JM, Sareen J, Walker JR, Singer A, Lix LM, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; Canadian Institutes of Health Research Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Arthritis Care Res (Hoboken). 2018 Jul;70(7):970-978. doi: 10.1002/acr.23539. Epub 2018 May 21.

13.

Physical comorbidities increase the risk of psychiatric comorbidity in immune-mediated inflammatory disease.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Gen Hosp Psychiatry. 2018 Mar - Apr;51:71-78. doi: 10.1016/j.genhosppsych.2018.01.003. Epub 2018 Jan 11.

PMID:
29353127
14.

Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study.

Marrie RA, Graff L, Walker JR, Fisk JD, Patten SB, Hitchon CA, Lix LM, Bolton J, Sareen J, Katz A, Berrigan LI, Marriott JJ, Singer A, El-Gabalawy R, Peschken CA, Zarychanski R, Bernstein CN.

JMIR Res Protoc. 2018 Jan 17;7(1):e15. doi: 10.2196/resprot.8794.

15.

The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis.

Marrie RA, Zhang L, Lix LM, Graff LA, Walker JR, Fisk JD, Patten SB, Hitchon CA, Bolton JM, Sareen J, El-Gabalawy R, Marriott JJ, Bernstein CN.

Mult Scler Relat Disord. 2018 Feb;20:9-15. doi: 10.1016/j.msard.2017.12.007. Epub 2017 Dec 16.

16.

Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

BMC Res Notes. 2017 Nov 25;10(1):619. doi: 10.1186/s13104-017-2958-1.

17.

Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Epidemiol Psychiatr Sci. 2019 Jun;28(3):333-342. doi: 10.1017/S2045796017000579. Epub 2017 Nov 3.

PMID:
29098977
18.

Increased incidence of psychiatric disorders in immune-mediated inflammatory disease.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

J Psychosom Res. 2017 Oct;101:17-23. doi: 10.1016/j.jpsychores.2017.07.015. Epub 2017 Aug 1.

19.

Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis.

Scally SW, Law SC, Ting YT, Heemst JV, Sokolove J, Deutsch AJ, Bridie Clemens E, Moustakas AK, Papadopoulos GK, van der Woude D, Smolik I, Hitchon CA, Robinson DB, Ferucci ED, Bernstein CN, Meng X, Anaparti V, Huizinga T, Kedzierska K, Reid HH, Raychaudhuri S, Toes RE, Rossjohn J, El-Gabalawy H, Thomas R.

Ann Rheum Dis. 2017 Nov;76(11):1915-1923. doi: 10.1136/annrheumdis-2017-211300. Epub 2017 Aug 11.

PMID:
28801345
20.

Markedly increased incidence of critical illness in adults with Type 1 diabetes.

Marrie RA, Sellers EAC, Chen H, Fransoo R, Bernstein CN, Hitchon CA, Peschken CA, Garland A.

Diabet Med. 2017 Oct;34(10):1414-1420. doi: 10.1111/dme.13404. Epub 2017 Jul 12.

PMID:
28626956
21.

Hospitalization is associated with subsequent disability in multiple sclerosis.

Garland A, Metz LM, Bernstein CN, Peschken CA, Hitchon CA, Marrie RA.

Mult Scler Relat Disord. 2017 May;14:23-28. doi: 10.1016/j.msard.2017.03.009. Epub 2017 Mar 24.

22.

Health care utilisation before and after intensive care unit admission in rheumatoid arthritis.

Marrie RA, Hitchon CA, Peschken CA, Chen H, Bernstein CN, Garland A.

Clin Exp Rheumatol. 2017 Nov-Dec;35(6):975-982. Epub 2017 Jun 5.

PMID:
28598781
23.

Increased Incidence of Critical Illness in Psoriasis.

Marrie RA, Bernstein CN, Peschken CA, Hitchon CA, Chen H, Garland A.

J Cutan Med Surg. 2017 Sep/Oct;21(5):395-400. doi: 10.1177/1203475417712497. Epub 2017 Jun 6.

PMID:
28587481
24.

Systematic Review and Meta-analysis of Interventions for Depression and Anxiety in Persons With Rheumatoid Arthritis.

Fiest KM, Hitchon CA, Bernstein CN, Peschken CA, Walker JR, Graff LA, Zarychanski R, Abou-Setta A, Patten SB, Sareen J, Bolton J, Marrie RA; CIHR Team “Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease”.

J Clin Rheumatol. 2017 Dec;23(8):425-434. doi: 10.1097/RHU.0000000000000489. Review.

25.

Screening Tools for Anxiety in People with Multiple Sclerosis: A Systematic Review.

Litster B, Fiest KM, Patten SB, Fisk JD, Walker JR, Graff LA, Bolton JM, Sareen J, Marriott JJ, Berrigan LI, Bernstein CN, Zarychanski R, Singer A, Hitchon CA, Peschken CA, Marrie RA; CIHR Team “Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease”.

Int J MS Care. 2016 Nov-Dec;18(6):273-281. doi: 10.7224/1537-2073.2016-004.

26.

Characterization of Autoantigens Targeted by Anti-Citrullinated Protein Antibodies In Vivo: Prominent Role for Epitopes Derived from Histone 4 Proteins.

Meng X, Ezzati P, Smolik I, Bernstein CN, Hitchon CA, El-Gabalawy HS.

PLoS One. 2016 Oct 27;11(10):e0165501. doi: 10.1371/journal.pone.0165501. eCollection 2016.

27.

Reply.

Hitchon CA, Koppejan H, Trouw LA, Huizinga TJ, Toes RE, El-Gabalawy HS.

Arthritis Rheumatol. 2016 Nov;68(11):2826-2827. doi: 10.1002/art.39831. Epub 2016 Oct 9. No abstract available.

28.

Systematic review of interventions for depression and anxiety in persons with inflammatory bowel disease.

Fiest KM, Bernstein CN, Walker JR, Graff LA, Hitchon CA, Peschken CA, Zarychanski R, Abou-Setta A, Patten SB, Sareen J, Bolton J, Singer A, Marrie RA; CIHR Team “Defining the burden and managing the effects of psychiatric comorbidity in chronic immunoinflammatory disease”.

BMC Res Notes. 2016 Aug 12;9(1):404. doi: 10.1186/s13104-016-2204-2. Review.

29.

Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis Cohort.

Hitchon CA, Boire G, Haraoui B, Keystone E, Pope J, Jamal S, Tin D, Thorne C, Bykerk VP; CATCH investigators.

Rheumatology (Oxford). 2016 Oct;55(10):1751-62. doi: 10.1093/rheumatology/kew061. Epub 2016 Jun 21.

PMID:
27330161
30.

Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.

Koppejan H, Trouw LA, Sokolove J, Lahey LJ, Huizinga TJ, Smolik IA, Robinson DB, El-Gabalawy HS, Toes RE, Hitchon CA.

Arthritis Rheumatol. 2016 Sep;68(9):2090-8. doi: 10.1002/art.39664.

31.

High rates of obesity and greater associated disability among people with rheumatoid arthritis in Canada.

Colmegna I, Hitchon CA, Bardales MC, Puri L, Bartlett SJ.

Clin Rheumatol. 2016 Feb;35(2):457-60. doi: 10.1007/s10067-015-3154-0. Epub 2015 Dec 28.

PMID:
26712499
32.

A Population-based Study of Intensive Care Unit Admissions in Rheumatoid Arthritis.

Peschken CA, Hitchon CA, Garland A, Bernstein CN, Chen H, Fransoo R, Marrie RA.

J Rheumatol. 2016 Jan;43(1):26-33. doi: 10.3899/jrheum.150312. Epub 2015 Dec 1.

33.

Heterogeneous Disease Trajectories Explain Variable Radiographic, Function and Quality of Life Outcomes in the Canadian Early Arthritis Cohort (CATCH).

Barnabe C, Sun Y, Boire G, Hitchon CA, Haraoui B, Thorne JC, Tin D, van der Heijde D, Curtis JR, Jamal S, Pope JE, Keystone EC, Bartlett S, Bykerk VP; CATCH Investigators.

PLoS One. 2015 Aug 24;10(8):e0135327. doi: 10.1371/journal.pone.0135327. eCollection 2015.

34.

Health care utilization before and after intensive care unit admission in multiple sclerosis.

Marrie RA, Bernstein CN, Peschken CA, Hitchon CA, Chen H, Fransoo R, Garland A.

Mult Scler Relat Disord. 2015 Jul;4(4):296-303. doi: 10.1016/j.msard.2015.05.010. Epub 2015 May 30.

35.

Predictors of ICU Admission and Outcomes 1 Year Post-Admission in Persons with IBD: A Population-based Study.

Bernstein CN, Garland A, Peschken CA, Hitchon CA, Chen H, Fransoo R, Marrie RA.

Inflamm Bowel Dis. 2015 Jun;21(6):1341-7. doi: 10.1097/MIB.0000000000000363.

36.

Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients.

Curtis JR, Yang S, Chen L, Pope JE, Keystone EC, Haraoui B, Boire G, Thorne JC, Tin D, Hitchon CA, Bingham CO 3rd, Bykerk VP.

Arthritis Care Res (Hoboken). 2015 Oct;67(10):1345-53. doi: 10.1002/acr.22606.

37.

The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritis.

Hazlewood GS, Thorne JC, Pope JE, Lin D, Tin D, Boire G, Haraoui B, Hitchon CA, Keystone EC, Jamal S, Bykerk VP; CATCH Investigators.

Ann Rheum Dis. 2016 Jun;75(6):1003-8. doi: 10.1136/annrheumdis-2014-206504. Epub 2015 May 15.

PMID:
25979945
38.

Does socioeconomic status affect outcomes in early inflammatory arthritis? Data from a canadian multisite suspected rheumatoid arthritis inception cohort.

Yang G, Bykerk VP, Boire G, Hitchon CA, Thorne JC, Tin D, Haraoui B, Keystone EC, Pope JE; CATCH Investigators.

J Rheumatol. 2015 Jan;42(1):46-54. doi: 10.3899/jrheum.131382. Epub 2014 Nov 15.

PMID:
25399388
39.

Effect of age at menopause on disease presentation in early rheumatoid arthritis: results from the Canadian Early Arthritis Cohort.

Wong LE, Huang WT, Pope JE, Haraoui B, Boire G, Thorne JC, Hitchon CA, Tin D, Keystone EC, Bykerk VP; Canadian Early Arthritis Cohort Investigators.

Arthritis Care Res (Hoboken). 2015 May;67(5):616-23. doi: 10.1002/acr.22494.

40.

Intensive care unit admission in multiple sclerosis: increased incidence and increased mortality.

Marrie RA, Bernstein CN, Peschken CA, Hitchon CA, Chen H, Fransoo R, Garland A.

Neurology. 2014 Jun 10;82(23):2112-9. doi: 10.1212/WNL.0000000000000495. Epub 2014 May 7.

41.

Increased incidence of critical illness among patients with inflammatory bowel disease: a population-based study.

Marrie RA, Garland A, Peschken CA, Hitchon CA, Chen H, Fransoo R, Bernstein CN.

Clin Gastroenterol Hepatol. 2014 Dec;12(12):2063-70.e1-4. doi: 10.1016/j.cgh.2014.03.033. Epub 2014 Apr 12.

PMID:
24726908
42.

Determining best practices in early rheumatoid arthritis by comparing differences in treatment at sites in the Canadian Early Arthritis Cohort.

Harris JA, Bykerk VP, Hitchon CA, Keystone EC, Thorne JC, Boire G, Haraoui B, Hazlewood G, Bonner AJ, Pope JE; CATCH Investigators.

J Rheumatol. 2013 Nov;40(11):1823-30. doi: 10.3899/jrheum.121316. Epub 2013 Sep 15.

PMID:
24037554
43.

Anticitrullinated protein antibodies and rheumatoid factor fluctuate in early inflammatory arthritis and do not predict clinical outcomes.

Barra L, Bykerk V, Pope JE, Haraoui BP, Hitchon CA, Thorne JC, Keystone EC, Boire G; Catch Investigators.

J Rheumatol. 2013 Aug;40(8):1259-67. doi: 10.3899/jrheum.120736. Epub 2013 Feb 1.

PMID:
23378461
44.

Pregnancy and the risk of rheumatoid arthritis in a highly predisposed North American Native population.

Peschken CA, Robinson DB, Hitchon CA, Smolik I, Hart D, Bernstein CN, El-Gabalawy HS.

J Rheumatol. 2012 Dec;39(12):2253-60. doi: 10.3899/jrheum.120269. Epub 2012 Oct 15.

PMID:
23070994
45.

Time to disease-modifying antirheumatic drug treatment in rheumatoid arthritis and its predictors: a national, multicenter, retrospective cohort.

Tavares R, Pope JE, Tremblay JL, Thorne C, Bykerk VP, Lazovskis J, Blocka KL, Bell MJ, Lacaille D, Hitchon CA, Fitzgerald AA, Fidler WK, Bookman AA, Henderson JM, Mosher DP, Sholter DE, Khraishi M, Haraoui B, Chen H, Li X, Laupacis A, Boire G, Tomlinson G, Bombardier C.

J Rheumatol. 2012 Nov;39(11):2088-97. doi: 10.3899/jrheum.120100. Epub 2012 Aug 15.

PMID:
22896027
46.

The Canadian Early Arthritis Cohort (CATCH): patients with new-onset synovitis meeting the 2010 ACR/EULAR classification criteria but not the 1987 ACR classification criteria present with less severe disease activity.

Bykerk VP, Jamal S, Boire G, Hitchon CA, Haraoui B, Pope JE, Thorne JC, Sun Y, Keystone EC.

J Rheumatol. 2012 Nov;39(11):2071-80. doi: 10.3899/jrheum.120029. Epub 2012 Aug 15.

PMID:
22896026
47.

Vitamin D receptor polymorphism rs2228570 (Fok1) is associated with rheumatoid arthritis in North American natives.

Hitchon CA, Sun Y, Robinson DB, Peschken CA, Bernstein CN, Siminovitch KA, El-Gabalawy HS.

J Rheumatol. 2012 Sep;39(9):1792-7. doi: 10.3899/jrheum.120387. Epub 2012 Aug 1.

PMID:
22859341
48.

Incidence and predictors of secondary fibromyalgia in an early arthritis cohort.

Lee YC, Lu B, Boire G, Haraoui BP, Hitchon CA, Pope JE, Thorne JC, Keystone EC, Solomon DH, Bykerk VP.

Ann Rheum Dis. 2013 Jun;72(6):949-54. doi: 10.1136/annrheumdis-2012-201506. Epub 2012 Jul 11.

49.

Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort.

McKeown E, Bykerk VP, De Leon F, Bonner A, Thorne C, Hitchon CA, Boire G, Haraoui B, Ferland DS, Keystone EC, Pope JE; CATCH Investigators.

Rheumatology (Oxford). 2012 Sep;51(9):1662-9. Epub 2012 Apr 25.

PMID:
22539481
50.

Familial clustering of the serum cytokine profile in the relatives of rheumatoid arthritis patients.

El-Gabalawy HS, Robinson DB, Smolik I, Hart D, Elias B, Wong K, Peschken CA, Hitchon CA, Li X, Bernstein CN, Newkirk MM, Fritzler MJ.

Arthritis Rheum. 2012 Jun;64(6):1720-9. doi: 10.1002/art.34449. Epub 2012 Feb 21.

Supplemental Content

Loading ...
Support Center